Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer

1. Yu, H.A.
2. Paz-Ares, L.G.
3. Yang, J.C.-H.
4. Lee, K.H.
5. Garrido, P.
6. Park, K.
7. Kim, J.-H.
8. Lee, D.H.
9. Mao, H.
10. Wijayawardana, S.R.
11. Gao, L.
12. Hozak, R.R.
13. Chao, B.H.
14. Planchard, D.